[Apolipoprotein E(ApoE)and tau protein in Alzheimer type dementia]

Pol Merkur Lekarski. 2000 Nov;9(53):758-9.
[Article in Polish]

Abstract

In 45 patients meeting NINCDS-ARDRA criteria for probably diagnosis of Alzheimer disease (AD), ApoE genotype and tau protein level in cerebro-spinal fluid (CSF) were determined. Frequency of e4 allele occurrence in group of AD patients was 73.3% and showed high statistic significance in comparison with control group. Increase of tau protein level in CSF was also statistically significant. No correlation in ApoE allele and tau protein level in CSF was revealed. The authors emphasize the usefulness of tau protein level measurement and determination of ApoE allele in diagnosis of Alzheimer disease.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • English Abstract

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / cerebrospinal fluid
  • Alzheimer Disease / diagnosis*
  • Apolipoproteins E / genetics*
  • Biomarkers / cerebrospinal fluid
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • tau Proteins / cerebrospinal fluid*

Substances

  • Apolipoproteins E
  • Biomarkers
  • tau Proteins